Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/603520 stock hub

SHA/603520 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/603520is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
5.2B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/603520
In the news

Latest news · SHA/603520

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E40.9
P25 17.1P50 24.2P75 37.8
Trailing P/E308.8
P25 23.5P50 41.3P75 83.2
ROE0.6
P25 -0.9P50 4.1P75 8.8
ROIC2.8
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/603520 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
215
Groups with data
11
Currency
CNY
Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
1,754
Employees Change
-91%
Employees Change Percent
-4.93
Enterprise value
CNY 7.9B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CNE1000026N8
Last refreshed
2026-05-10
Market cap
CNY 5.2B
Price
CNY 11.86
Price currency
CNY
Rev Per Employee
1,408,862.82x
Sector
Healthcare
Sic
2833
Symbol
sha/603520
Website
https://www.starrypharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
0.32%
EV Earnings
467.16x
EV/EBIT
49.77x
EV/EBITDA
19.18x
EV/FCF
-19.7x
EV/Sales
3.18x
FCF yield
-7.68%
Forward P/E
40.9x
P/B ratio
2.01x
P/E ratio
308.8x
P/S ratio
2.1x
PE Ratio10 Y
82.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
6.25%
EBITDA Margin
16.18%
Gross margin
21.83%
Gross Profit
CNY 539.5M
Gross Profit Growth
23.62%
Gross Profit Growth Q
29.3%
Gross Profit Growth3 Y
5.7%
Gross Profit Growth5 Y
-3.02%
Net Income
CNY 16.8M
Net Income Growth Q
46.08%
Net Income Growth Quarters
3%
Net Income Growth Years
0%
Net Income Growth5 Y
-42.05%
Pretax Margin
0.74%
Profit Margin
0.68%
Profit Per Employee
CNY 9,600
ROA
1.54
Roa5y
2.29
ROCE
3.9
ROE
0.64
Roe5y
2.65
ROIC
2.75
Roic5y
4.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

15
MetricValue
Cagr10y
-2.17%
Cagr1y
39.84%
Cagr3y
-11.03%
Cagr5y
-22.63%
Div CAGR3
-33.06%
Div CAGR5
-17.94%
EPS Growth Q
66.67
EPS Growth Quarters
2
EPS Growth Years
0
EPS Growth5 Y
-46.37
Revenue Growth
3.23x
Revenue Growth Q
3.7x
Revenue Growth Years
8x
Revenue Growth3 Y
4.27x
Revenue Growth5 Y
11.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
CNY 0.4
Assets
CNY 6.3B
Cash
CNY 308M
Current Assets
CNY 2.4B
Current Liabilities
CNY 2.3B
Debt
CNY 3B
Debt EBITDA
CNY 7.3
Debt Equity
CNY 1.15
Debt FCF
CNY -7.43
Equity
CNY 2.6B
Liabilities
CNY 3.7B
Long Term Assets
CNY 3.9B
Long Term Liabilities
CNY 1.4B
Net Cash
CNY -2.7B
Net Cash By Market Cap
CNY -51.16
Net Debt EBITDA
CNY 6.65
Net Debt Equity
CNY 1.03
Tangible Book Value
CNY 1.9B
Tangible Book Value Per Share
CNY 4.5
WACC
4.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.02
Inventory Turnover
1.73
Net Working Capital
CNY 1.5B
Quick ratio
0.48
Working Capital
CNY 53.6M
Working Capital Turnover
CNY -12.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Buyback Yield
-9.9%
Dividend Growth
200%
Dividend Growth Years
1%
Dividend per share
CNY 0.2
Dividend Years
10
Dividend Yield
1.69%
Last Dividend
CNY 0.05
Payout Ratio
850.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-19.7%
1Y total return
39.81%
200-day SMA
10.68
3Y total return
-29.57%
50-day SMA
10.58
50-day SMA vs 200-day SMA
50under200
5Y total return
-72.28%
All Time High
70.36
All Time High Change
-83.14%
All Time High Date
2020-09-01
All Time Low
6.13
All Time Low Change
93.38%
All Time Low Date
2018-10-19
ATR
0.45
Beta
0.61
Beta1y
0.55
Beta2y
0.58
Ch YTD
26.17
High
11.97
High52
12.82
High52 Date
2025-09-15
High52ch
-7.49%
Low
11.72
Low52
8.46
Low52 Date
2025-05-09
Low52ch
40.19%
Ma50ch
12.12%
Price vs 200-day SMA
11.02%
RSI
61.05
RSI Monthly
50.22
RSI Weekly
63.06
Sharpe ratio
1.07x
Sortino ratio
2.07
Total Return
-8.21%
Tr YTD
26.17
Tr1m
11.89%
Tr1w
-3.81%
Tr3m
11.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 154.4M
Operating Income Growth
71.77
Operating Income Growth Q
64.64
Operating Income Growth3 Y
23.43
Operating Income Growth5 Y
-15.83
Operating margin
6.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
319,179,012%
Net Borrowing
232,340,054
Shares Insiders
25.52%
Shares Institutions
20.12%
Shares Out
438,409,881
Shares Qo Q
-48.28%
Shares Yo Y
9.9%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
CNY -399.3M
Average Volume
30,012,319.6x
Bv Per Share
6.14
CAPEX
CNY -245.8M
Ch10y
-27.57
Ch1m
11.89
Ch1w
-3.81
Ch1y
37.91
Ch3m
11.36
Ch3y
-31.8
Ch5y
-73.65
Ch6m
7.23
Change
-2.06%
Change From Open
0.85
Close
12.11
Days Gap
-2.89
Depreciation Amortization
245,423,493
Dollar Volume
389,150,509.8
Earnings Date
2026-04-30
EBIT
CNY 154.4M
EBITDA
CNY 399.8M
EPS
CNY 0.03
F Score
4
FCF
CNY -399.3M
FCF EV Yield
-5.08x
FCF Per Share
CNY -0.91
Financing CF
303,294,807
Fiscal Year End
December
Founded
1,997
Goodwill
404,959,974
Graham Number
2.16499
Graham Upside
-81.75
Income Tax
CNY 1.6M
Investing CF
-235,297,563
Is Primary Listing
1
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Last Split Date
2022-06-17
Last Split Type
Forward
Lynch Fair Value
CNY 0.17
Lynch Upside
-98.57
Ma150
10.51
Ma150ch
12.84%
Ma20
11.29
Ma20ch
5.06%
Net CF
-63,114,773
Next Earnings Date
2026-08-21
Open
11.76
Payment Date
2025-09-12
Position In Range
56
Ppne
3,010,839,603
Price Date
2026-05-08
Price EBITDA
CNY 13.01
Ptbv Ratio
2.76
Relative Volume
1.12x
Revenue
2,471,145,380x
Tax By Revenue
0.06x
Tax Rate
8.44%
Tr6m
7.23%
Volume
32,812,016
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHA/603520 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.7%
$0.20 annual per share
Payout ratio
+850.6%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-17.9%
1 consecutive years of growth
Total shareholder yield
-8.2%
Dividend yield + buyback yield combined
Performance

SHA/603520 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+39.8%
S&P 500 1Y: n/a
3Y total return
-29.6%
S&P 500 3Y: n/a
5Y total return
-72.3%
S&P 500 5Y: n/a
10Y total return
-19.7%
S&P 500 10Y: n/a
Ownership

Who owns SHA/603520?

Insider, institutional, and short-interest positioning.

Institutional ownership
+20.1%
Share of float held by funds and institutions
Insider ownership
+25.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+9.9%
Negative means the company is buying back shares.
Technical

SHA/603520 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
61.0
Neutral momentum band
Price vs 200-day MA
+11.0%
50/200-day relationship not available
Beta (5Y)
0.61
Less volatile than the market
Sharpe ratio
1.07
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/603520

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/603520 stock rating?

sha/603520 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/603520 analysis?

The full report lives at /stocks/sha/603520/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/603520?

The latest report frames sha/603520 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/603520 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

sha/603520 stock profile: metrics, valuation and analysis | Agente de Mercado de Ações com IA